All DR-TB patients registered from September 2010 (the start of DR-TB treatment in the Amhara region) to December 2017 at the University of Gondar, Boru-Meda, Debre-Markos, and Woldia Hospital were included in the study.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.